KR-333

N/A

Report date: 2022/05/10 11:43:51
NME

Base Information

Drug NameKR-333
Drug Alias NameKR333
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionCell death stimulantsImmunomodulators
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKernal Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKernal Biologics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A